Role of p21CIP1 as a determinant of SC-560 response in human HCT116 colon carcinoma cells

Experimental and Molecular Medicine

Volumn 38, Issue 3, 2006, Pages 325-331

  Lee, Eunmyong ^a   Choi, Moon Kyung ^b   Han, Inn Oc ^c   Lim, Soo Jeong ^a,c  

^a Sejong University   (South Korea)

^b National Cancer Center   (South Korea)

^c Inha University School of Medicine   (South Korea)

Author keywords

Apoptosis; Caspase; Cell cycle; Cyclin dependent kinase inhibitor p21; Growth inhibitors; HCT116 cells; SC 560

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CASPASE; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL STRAIN HCT116; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; UPREGULATION;

EID: 33745860963     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2006.39     Document Type: Article

References (26)

1. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, Mizutani S. Apoptosis inhibitory activity of cytoplasmic p21 (Cip1/WAF1) in monocytic differentiation. Embo J 1999;18:1223-34
2. Boonstra J, Post JA. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 2004;337:1-13
3. Chung YW, Jeong DW, Won JY, Choi EJ, Choi YH, Kim IY. H(2)O(2)-induced AP-1 activation and its effect on p21 (WAF1/CIP1)-mediated G2/M arrest in a p53-deficient human lung cancer cell. Biochem Biophys Res Commun 2002;293:1248-53
4. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F. Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808
5. Davies NM, Gudde TW, de Leeuw MA. Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis. Expert Opin Pharmacother 2001;2:139-52
6. De Schepper S, Bruwiere H, Verhulst T, Steller U, Andries L, Wouters W, Janicot M, Arts J, Van Heusden J. Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin. J Pharmacol Exp Ther 2003;304:881-8
7. Dotto GP. p21 (WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 2000;1471:M43-56
8. Fotedar R, Bendjennat M, Fotedar A. Functional analysis of CDK inhibitor p21WAF1. Methods Mol Biol 2004;81:55-71
9. Gong X, Wang M, Wu Z, Tashiro SI, Onodera S, Ikejima T. Pseudolaricacid B induces apoptosis via activation of c-Jun N-terminal kinase and caspase-3 in HeLa cells. Exp Mol Med 2004;36:551-6
10. Gorospe M, Cirielli C, Wang X, Seth P, Capogrossi MC, Holbrook NJ. p21 (Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene 1997;14:929-35
11. Grosch S, Tegeder I, Niederberger, E, Brautigam L, Geisslinger G. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. Faseb J 2001;15:2742-4
12. Javelaud D, Besancon F. Inactivation of p21WAF1 sensitizes cells to apoptosis via an increase of both p14ARF and p53 levels and an alteration of the Bax/Bcl-2 ratio. J Biol Chem 2002;277:37949-54
13. Kang HK, Lee E, Pyo H, Lim SJ. Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells. Mol Cancer Ther 2005;4:1358-63
14. Kang YH, Lee E, Choi MK, Ku JL, Kim SH, Park YG, Lim SJ. Role of reactive oxygen species in the induction of apoptosis by alpha-tocopheryl succinate. Int J Cancer 2004;112:385-92
15. Kim YS, Jhon DY, Lee KY. Involvement of ROS and JNK1 in selenite-induced apoptosis in Chang liver cells. Exp Mol Med 2004;36:157-64
16. Kundu N, Smyth MJ, Samsel L, Fulton AM. Cyclooxygenase inhibitors blockcell growth, increase ceramide and inhibit cell cycle. Breast Cancer Res Treat 2002;76:57-64
17. Liu S, Bishop WR, Liu M. Differential effects of cell cycle regulatory protein p21 (WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat 2003;6:183-95
18. Macip S, Igarashi M, Fang L, Chen A, Pan ZQ, Lee SW, Aaronson SA. Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. Embo J 2002; 21:2180-8
19. Prabhu NS, Blagosklonny MV, Zeng YX, Wu GS, Waldman T, El-Deiry WS. Suppression of cancer cell growth by adenovirus expressing p21 (WAF1/CIP1) deficient in PCNA interaction. Clin Cancer Res 1996;2:1221-9
20. Qiao L, McKinstry R, Gupta S, Gilfor D, Windle JJ, Hylemon PB, Grant S, Fisher PB, Dent P. Cyclin kinase inhibitor p21 potentiates bile acid-induced apoptosis in hepatocytes that is dependent on p53. Hepatology 2002;36:39-48
21. Qin LF, Ng IO. Exogenous expression of p21 (WAF1/CIP1) exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells. Cancer Lett 2001;172:7-15
22. Shim J, Lee H, Park J, Kim H, Choi EJ. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 1996;381:804-6
23. Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 1998;17:931-9
24. Waldman T, Kinzler KW, Vogelstein B. p21 is necessary for the p53-mediated G1 arrest inhuman cancer cells. Cancer Res 1995;55:5187-90
25. Wang JA, Fan S, Yuan RQ, Ma YX, Meng Q, Goldberg ID, Rosen EM. Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53. Int J Radiat Biol 1999;75:301-16
26. Zang Y, Beard RL, Chandraratna RA, Kang JX. Evidence of a lysosomal pathway for apoptosis induced by the synthetic retinoid CD437 in human leukemia HL-60 cells. Cell Death Differ 2001;8:477-85